1237165004: Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Gemtuzumab ozogamicin\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing gemtuzumab ozogamicin\Gemtuzumab ozogamicin\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing immunomodulator\Product containing gemtuzumab ozogamicin\Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing gemtuzumab ozogamicin\Gemtuzumab ozogamicin\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing polypeptide\Product containing protein\Product containing antibody\Product containing monoclonal antibody\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing gemtuzumab ozogamicin\Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing gemtuzumab ozogamicin\Gemtuzumab ozogamicin\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product)\Product containing gemtuzumab ozogamicin\Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)
\Medicinal product\Product manufactured as parenteral dose form\Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing only gemtuzumab ozogamicin in parenteral dose form (medicinal product form)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)\Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

5090884015 Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial en Synonym Active Entire term case insensitive SNOMED CT core module

5090885019 Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Is a	Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)	true	Inferred relationship	Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has manufactured dose form	Powder for conventional release solution for infusion	true	Inferred relationship	Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has unit of presentation	Vial	true	Inferred relationship	Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Plays role	Antineoplastic therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has precise active ingredient	Gemtuzumab ozogamicin	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has basis of strength substance	Gemtuzumab ozogamicin	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	Has presentation strength denominator unit	Vial	true	Inferred relationship	Existential restriction modifier	1

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5090884015	Gemtuzumab ozogamicin 5 mg powder for solution for infusion vial	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
5090885019	Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module